Controlled release polymeric ocular delivery of acyclovir
- 23 June 2010
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 15 (4) , 369-378
Abstract
The aim of the present study was to formulate and evaluate controlled release polymeric ocular delivery of acyclovir. Reservoir-type ocular inserts were fabricated by sandwiching hydroxypropyl methylcellulose (HPMC) matrix film containing acyclovir between two rate controlling membranes of cellulose acetate phthalate (CAP). The solubility and dissolution rate of poorly soluble acyclovir was enhanced by preparing binary systems with β-cyclodextrin and then incorporated into HPMC matrix. Nine formulations (AB-1 to AB-9) with varying ratio of HPMC (drug matrix) and CAP (rate controlling membrane) were developed and sterilized by gamma radiation. The formulations were subjected to various physico-chemical evaluations. The in vitro release profile of all the formulations showed a steady, controlled drug release up to 20 h with non-Fickian diffusion behavior. A high correlation coefficient found between in vitro/in vivo release rate studies. Formation of acyclovir complex was confirmed by differential scanning calorimetry. In addition, dissolution rate studies revealed improved solubility of acyclovir when complexed with β-cyclodextrin. Stability studies showed that the ocular inserts could be stored safely at study storage conditions. In conclusion, the present study demonstrated controlled release formulation of acyclovir inserts for ocular delivery using biodegradable polymers.Keywords
This publication has 15 references indexed in Scilit:
- Preformulation study of the inclusion complex warfarin-β-cyclodextrinInternational Journal of Pharmaceutics, 2005
- Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin systemJournal of Pharmacy and Pharmacology, 2004
- Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humansJournal of Controlled Release, 2003
- Ophthalmic Delivery of Ciprofloxacin Hydrochloride from Different Polymer Formulations: In Vitro and In Vivo StudiesDrug Development and Industrial Pharmacy, 2003
- Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugsJournal of Controlled Release, 2001
- Ocular Tolerability and In Vivo Bioavailability of Poly(ethylene glycol) (PEG)‐Coated Polyethyl‐2‐Cyanoacrylate Nanosphere‐Encapsulated AcyclovirJournal of Pharmaceutical Sciences, 2001
- Inclusion complex of the antiviral drug acyclovir with cyclodextrin in aqueous solution and in solid phaseQuímica Nova, 2000
- Ocular inserts for topical deliveryAdvanced Drug Delivery Reviews, 1995
- Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery systemJournal of Controlled Release, 1993
- An investigation into the role of water movement and mucus gel dehydration in mucoadhesionJournal of Controlled Release, 1993